![Amgen to be the Worst Hit from US Biosimilar Erosion During 2011 â€]()
A new report from IMARC Group expects Amgen to lose brand sales worth US$ 8.4 Billion during 2010 and 2020 mainly as a result of biosimilar erosion. IMARC Group, one of the world's leading research and advisory firms, expects biopharmaceutical giant ... Amgen to be the Worst Hit from US Biosimilar Erosion During 2011 â€" 2020
No comments:
Post a Comment